1. Musculoskeletal clinical metrology;Bellamy, N.,1993
2. Guidelines for the clinical evaluan of drugs used in rheumatic diseases. European Drug Guidelines Series 5, World Health Organisation, Regional Office for Europe,1985
3. Guidelines for the clinical evaluation of anti-inflammatory and antirheumatic drugs (Adults and Children),1988
4. Guidelines for testing slow acting drugs in osteoarthritis;Lequesne, M.; Brandt, K.; Bellamy, N.;JRheumatol,1994
5. Validation study of WOMAC: a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee;Bellamy, N.; W, Buchanan W.; H, Goldsmith C.; Campbell, J.; W, Stitt L.;J Rheumatol,1988